POLR2J4 and hepatocellular carcinoma: miR-214-3p, predicted to bind with POLR2J4, showed significant downregulation in HBV–HCC tumor tissues (Figure 3A) and cells (Figure 3B) compared to normal tissues, cells, and non-HBV cells (P < .001).